- Home
- ATNM vs HYPR Comparison
ATNM vs HYPR Comparison
Compare ATNM & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- HYPR
- Stock Information
- Founded
- ATNM 2000
- HYPR 2014
- Country
- ATNM United States
- HYPR United States
- Employees
- ATNM N/A
- HYPR N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- HYPR Medical Specialities
- Sector
- ATNM Health Care
- HYPR Health Care
- Exchange
- ATNM Nasdaq
- HYPR Nasdaq
- Market Cap
- ATNM 50.2M
- HYPR 55.9M
- IPO Year
- ATNM N/A
- HYPR N/A
- Fundamental
- Price
- ATNM $1.63
- HYPR $1.39
- Analyst Decision
- ATNM Strong Buy
- HYPR Strong Buy
- Analyst Count
- ATNM 2
- HYPR 3
- Target Price
- ATNM $4.50
- HYPR $1.28
- AVG Volume (30 Days)
- ATNM 130.6K
- HYPR 249.0K
- Earning Date
- ATNM 11-13-2025
- HYPR 11-11-2025
- Dividend Yield
- ATNM N/A
- HYPR N/A
- EPS Growth
- ATNM N/A
- HYPR N/A
- EPS
- ATNM N/A
- HYPR N/A
- Revenue
- ATNM N/A
- HYPR $10,797,000.00
- Revenue This Year
- ATNM N/A
- HYPR $12.92
- Revenue Next Year
- ATNM N/A
- HYPR $32.10
- P/E Ratio
- ATNM N/A
- HYPR N/A
- Revenue Growth
- ATNM N/A
- HYPR N/A
- 52 Week Low
- ATNM $1.03
- HYPR $0.53
- 52 Week High
- ATNM $2.41
- HYPR $1.90
- Technical
- Relative Strength Index (RSI)
- ATNM 46.73
- HYPR 63.44
- Support Level
- ATNM $1.52
- HYPR $1.06
- Resistance Level
- ATNM $1.70
- HYPR $1.47
- Average True Range (ATR)
- ATNM 0.07
- HYPR 0.08
- MACD
- ATNM -0.01
- HYPR 0.01
- Stochastic Oscillator
- ATNM 36.71
- HYPR 80.49
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About HYPR Hyperfine Inc.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.